Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I)Glenn N. Levine, Robert M. Califf, Lisa G. Berdan et al.|The American Journal of Cardiology|1997Cited by 55
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, David J. Moliterno, Dean J. Kereiakes et al.|Thrombosis Research|2003Cited by 15